Skip to main content
Glama

Statbank Md

by io.github.pipeworx-io

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark the tool read-only, idempotent, and non-destructive, and the description adds substantial behavioral detail: it pulls specific SEC filings/FAERS data, handles off-calendar fiscal years, sorts results by primary metric, and returns paired data with citation URIs. No contradiction exists.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is longer than minimal, but each sentence adds essential information. It is front-loaded with trigger phrases and the key preference rule, followed by type-specific details and output characteristics. Slight redundancy in the example list, but no wasted content.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite lacking an output schema, the description clearly states what the tool returns (paired data, citation URIs, sorted results), covers data sources, and explains why it replaces many sequential lookups. This is sufficient for an agent to select and invoke the tool correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, and the description adds meaningful detail beyond the schema: it explains what each 'type' value pulls (company vs drug), and clarifies that 'values' accepts tickers/CIKs or drug names with examples. This helps the agent correctly populate parameters.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description uses a specific verb ('compare') with a clear resource (companies/drugs), and explicitly distinguishes from sibling tools by emphasizing parallel side-by-side comparison and 'ALWAYS PREFER over sequential single-pack lookups'. It also clarifies the two entity types and data sources.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly lists trigger phrases ('X vs Y', 'which is bigger', 'rank these companies') and provides an explicit preference rule over alternatives, as well as type-specific guidance. This gives unambiguous when-to-use direction.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Statbank Md toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation2/5

Multiple tools have overlapping purposes: ask_pipeworx, ask_pipeworx_beta, and ask_pipeworx_grounded are near-identical in scope, and the prediction-market tools (bet_research, polymarket_edges, polymarket_arbitrage, polymarket_fill_risk) share similar functions. While some tools are distinct, the boundaries between many are unclear.

Naming Consistency2/5

Names mix product-like identifiers (ask_pipeworx, deep_research), descriptive nouns (entity_profile, subjects), and inconsistent verb forms (query_table, resolve_entity, scan_competitor_ai_presence). No consistent verb_noun pattern is maintained across the set.

Tool Count2/5

With 34 tools, the server is overpopulated relative to its apparent purpose. The name 'Statbank Md' suggests a narrow statistical service, but only 3 tools are Statbank-specific; the rest form a sprawling general-purpose data toolkit. The count is far beyond what the core function needs.

Completeness3/5

For the Statbank subset, the surface is complete (browse subjects, get metadata, query data). As a general data research suite, it covers many domains (SEC, FDA, economics, prediction markets) but lacks execution/trading tools for prediction markets and has no bulk data export or analytics beyond excerpts. Notable gaps exist but many core workflows are covered.

Resources